Press releases
- Penumbra, Inc. Schedules Second Quarter 2024 Earnings Release and Conference Call for July 30, 2024
- Penumbra, Inc. to Present at the Truist Securities MedTech Conference
- Penumbra, Inc. to Present at the William Blair Growth Stock Conference
- Penumbra, Inc. Reports First Quarter 2024 Financial Results
- Penumbra, Inc. to Present at the RBC Capital Markets Global Healthcare Conference
- Penumbra Launches Lightning Flash 2.0 - Latest CAVT Technology Designed to Rapidly Remove Blood Clots
More ▼
Key statistics
As of last trade Penumbra Inc (0P8:DUS) traded at 172.95, 8.50% above its 52-week low of 159.40, set on Jun 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 172.85 |
---|---|
High | 172.95 |
Low | 172.85 |
Bid | 173.05 |
Offer | 176.10 |
Previous close | 172.20 |
Average volume | 0.00 |
---|---|
Shares outstanding | 38.76m |
Free float | 37.29m |
P/E (TTM) | 85.50 |
Market cap | 7.88bn USD |
EPS (TTM) | 2.38 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 08:10 BST.
More ▼